Form 8-K - Current report:
SEC Accession No. 0001213900-25-029927
Filing Date
2025-04-08
Accepted
2025-04-08 16:10:34
Documents
14
Period of Report
2025-04-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023744201-8k_abpro.htm   iXBRL 8-K 31480
  Complete submission text file 0001213900-25-029927.txt   251361

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abp-20250402.xsd EX-101.SCH 3878
3 XBRL DEFINITION FILE abp-20250402_def.xml EX-101.DEF 26771
4 XBRL LABEL FILE abp-20250402_lab.xml EX-101.LAB 36995
5 XBRL PRESENTATION FILE abp-20250402_pre.xml EX-101.PRE 25395
16 EXTRACTED XBRL INSTANCE DOCUMENT ea023744201-8k_abpro_htm.xml XML 5998
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 25822048
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)